Madrigal Pharmaceuticals
This role provides modality-focused development QA leadership for oral programs, ensuring phase-appropriate oversight, risk management, and compliant execution across internal teams and external partners. The position owns the program-level quality strategy, governance cadence, and readiness milestones while maintaining inspection-ready documentation. It involves partnering with CMC and clinical supply stakeholders on control strategy evolution, tech transfer readiness, and issue management to support efficient progression toward commercialization.
Headquarters
Conshohocken, Pennsylvania, United States
Company Size
201-500 employees
Founded
2016
Delivering a Breakthrough Treatment Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need. Left untreated, MASH can lead to progressive liver scarring, cirrhosis, liver failure, liver cancer, need for transplant and premature mortality. Our goal is to halt or reverse […]
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Madrigal Pharmaceuticals.
39% above the average for this role
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
2 weeks ago